APA

Palmerini T., Barozzi C., Tomasi L., Sangiorgi D., Marzocchi A., De Servi S., Ortolani P., Reggiani L. B., Alessi L., Lauria G., Bassi M. & Branzi A. (20100702). A randomised study comparing the antiplatelet and antiinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: results from the DOUBLE study. : Thrombosis research.

Chicago

Palmerini Tullio, Barozzi Chiara, Tomasi Luciana, Sangiorgi Diego, Marzocchi Antonio, De Servi Stefano, Ortolani Paolo, Reggiani Letizia Bacchi, Alessi Laura, Lauria Giulia, Bassi Mirna and Branzi Angelo. 20100702. A randomised study comparing the antiplatelet and antiinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: results from the DOUBLE study. : Thrombosis research.

Harvard

Palmerini T., Barozzi C., Tomasi L., Sangiorgi D., Marzocchi A., De Servi S., Ortolani P., Reggiani L. B., Alessi L., Lauria G., Bassi M. and Branzi A. (20100702). A randomised study comparing the antiplatelet and antiinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: results from the DOUBLE study. : Thrombosis research.

MLA

Palmerini Tullio, Barozzi Chiara, Tomasi Luciana, Sangiorgi Diego, Marzocchi Antonio, De Servi Stefano, Ortolani Paolo, Reggiani Letizia Bacchi, Alessi Laura, Lauria Giulia, Bassi Mirna and Branzi Angelo. A randomised study comparing the antiplatelet and antiinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: results from the DOUBLE study. : Thrombosis research. 20100702.